Bioworld
BCL6 Polyclonal Antibody - BS67101
BCL6 Polyclonal Antibody - BS67101
Couldn't load pickup availability
BCL6 Polyclonal Antibody
Sizes: 50μl, 100μl
Catalogue Numbers: BS67101-50, BS67101-100
Lead times: 1-2 weeks, if manufacturer has product in stock
Manufacturer/Ship Location: China
Background: Transcriptional repressor mainly required for germinal center (GC) formation and antibody affinity maturation which has different mechanisms of action specific to the lineage and biological functions. Forms complexes with different corepressors and histone deacetylases to repress the transcriptional expression of different subsets of target genes. Represses its target genes by binding directly to the DNA sequence 5'-TTCCTAGAA-3' (BCL6-binding site) or indirectly by repressing the transcriptional activity of transcription factors. In GC B-cells, represses genes that function in differentiation, inflammation, apoptosis and cell cycle control, also autoregμlates its transcriptional expression and up-regμlates, indirectly, the expression of some genes important for GC reactions, such as AICDA, through the repression of microRNAs expression, like miR155. An important function is to allow GC B-cells to proliferate very rapidly in response to T-cell dependent antigens and tolerate the physiological DNA breaks required for immunglobμlin class switch recombination and somatic hypermutation without inducing a p53/TP53-dependent apoptotic response. In follicμlar helper CD4+ T-cells (T(FH) cells), promotes the expression of T(FH)-related genes but inhibits the differentiation of T(H)1, T(H)2 and T(H)17 cells. Also required for the establishment and maintenance of immunological memory for both T- and B-cells. Suppresses macrophage proliferation through competition with STAT5 for STAT-binding motifs binding on certain target genes, such as CCL2 and CCND2. In response to genotoxic stress, controls cell cycle arrest in GC B-cells in both p53/TP53-dependedent and -independent manners. Besides, also controls neurogenesis through the alteration of the composition of NOTCH-dependent transcriptional complexes at selective NOTCH targets, such as HES5, including the recruitment of the deacetylase SIRT1 and resμlting in an epigenetic silencing leading to neuronal differentiation.
Category: Primary Antibody
Reactivity: Human, Mouse, Rat
Host: Rabbit
Applications: WB, IHC
Alternate Names: BCL5, LAZ3, ZBTB27, ZNF51, B-cell lymphoma 6 protein, BCL-6, B-cell lymphoma 5 protein, BCL-5, Protein LAZ-3, Zinc finger and BTB domain-containing protein 27, Zinc finger protein 51
Clonality: Polyclonal
Conjugate: Unconjugated
Modification: Unmodification
Immunogen: KLH-conjugated synthetic peptide encompassing a sequence within the center region of human BCL6. The exact sequence is proprietary.
Dilution: WB (1/500 - 1/1000), IH (1/100 - 1/200)
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).
Specificity: Recognizes endogenous levels of BCL6 protein.
Molecular Weight: ~ 95 kDa
Storage and Stability: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
SwissProt: P41182
Product: Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.
Research Use Only
